However, in the context of clinical ARDS, the relevance of this early SP-B reduction has not been investigated in detail although it has been suggested that surfactant inactivation plays a central role in the development of ARDS [17]. This evidence concerns the gene SFTPB and acute respiratory distress syndrome.